Chimerix Inc (CMRX)
0.9529
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.9548
0.00 (0.00%)
After-Hours: 20:00
Chimerix Cash from Financing (Quarterly): 0.062M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.062M |
| September 30, 2023 | 0.078M |
| June 30, 2023 | -0.031M |
| March 31, 2023 | 0.199M |
| December 31, 2022 | -0.032M |
| September 30, 2022 | 0.778M |
| June 30, 2022 | -0.011M |
| March 31, 2022 | -13.46M |
| December 31, 2021 | 0.052M |
| September 30, 2021 | 0.557M |
| June 30, 2021 | 0.117M |
| March 31, 2021 | 111.70M |
| December 31, 2020 | 0.346M |
| September 30, 2020 | 0.26M |
| June 30, 2020 | 0.578M |
| March 31, 2020 | 0.229M |
| December 31, 2019 | 0.001M |
| September 30, 2019 | 0.166M |
| June 30, 2019 | 0.018M |
| March 31, 2019 | 0.16M |
| December 31, 2018 | 0.37M |
| September 30, 2018 | 10.62M |
| June 30, 2018 | 0.055M |
| March 31, 2018 | 0.138M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.054M |
| September 30, 2017 | 0.336M |
| June 30, 2017 | 0.102M |
| March 31, 2017 | 0.395M |
| December 31, 2016 | 0.016M |
| September 30, 2016 | 0.407M |
| June 30, 2016 | 0.019M |
| March 31, 2016 | 0.166M |
| December 31, 2015 | -0.511M |
| September 30, 2015 | -0.01M |
| June 30, 2015 | 161.17M |
| March 31, 2015 | 0.701M |
| December 31, 2014 | 115.11M |
| September 30, 2014 | 0.145M |
| June 30, 2014 | 110.70M |
| March 31, 2014 | -0.70M |
| December 31, 2013 | -0.061M |
| September 30, 2013 | -0.898M |
| June 30, 2013 | 107.79M |
| March 31, 2013 | -0.667M |
| December 31, 2012 | 0.005M |
| September 30, 2012 | 11.95M |
| June 30, 2012 | 0.002M |
| March 31, 2012 | 0.361M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-13.46M
Minimum
Mar 2022
111.70M
Maximum
Mar 2021
5.348M
Average
0.117M
Median
Jun 2021
Cash from Financing (Quarterly) Benchmarks
| UFP Technologies Inc | -11.24M |
| Dentsply Sirona Inc | -14.00M |
| Arbutus Biopharma Corp | 3.807M |
| Pacira BioSciences Inc | -1.779M |
| Karyopharm Therapeutics Inc | 0.264M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.59M |
| Cash from Investing (Quarterly) | 28.07M |
| Free Cash Flow | -69.18M |
| Free Cash Flow Per Share (Quarterly) | -0.1641 |
| Free Cash Flow to Equity (Quarterly) | -14.59M |
| Free Cash Flow to Firm (Quarterly) | -14.59M |
| Free Cash Flow Yield | -81.93% |